ישראל -
עברית -
Ministry of Health
קבומטיקס 20 מג
medison pharma ltd - cabozantinib as (s) malate - טבליות מצופות פילם - cabozantinib as (s) malate 20 mg - cabozantinib
ישראל -
עברית -
Ministry of Health
קבומטיקס 40 מג
medison pharma ltd - cabozantinib as (s) malate - טבליות מצופות פילם - cabozantinib as (s) malate 40 mg - cabozantinib
ישראל -
עברית -
Ministry of Health
קבומטיקס 60 מג
medison pharma ltd - cabozantinib as (s) malate - טבליות מצופות פילם - cabozantinib as (s) malate 60 mg - cabozantinib
ישראל -
עברית -
Ministry of Health
סיטאגליפטין טבע 100 מג
teva israel ltd - sitagliptin as malate - טבליות מצופות פילם - sitagliptin as malate 100 mg - sitagliptin
ישראל -
עברית -
Ministry of Health
סיטאגליפטין טבע 25 מג
teva israel ltd - sitagliptin as malate - טבליות מצופות פילם - sitagliptin as malate 25 mg - sitagliptin
ישראל -
עברית -
Ministry of Health
סיטאגליפטין טבע 50 מג
teva israel ltd - sitagliptin as malate - טבליות מצופות פילם - sitagliptin as malate 50 mg - sitagliptin
ישראל -
עברית -
Ministry of Health
סוטנט 12.5 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 12.5 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
ישראל -
עברית -
Ministry of Health
סוטנט 25 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 25 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
ישראל -
עברית -
Ministry of Health
סוטנט 50 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 50 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
ישראל -
עברית -
Ministry of Health
רילרט 20 מג
pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - טבליות מצופות פילם - eletriptan hydrobromide 24.242 mg - eletriptan